Balancing demand and evidence: MTDM’s oversight of GLP-1 prescribing
Susanne Burns, Amanda Popko and Allison Cebulko
In response to the rising cost and growing demand for GLP-1 receptor agonists, Specialty MTDM, in collaboration with the Value & Strategy team, implemented a systemwide initiative designed to make sure prescribing practices remain clinically appropriate and financially sustainable. GLP-1 therapies,